- All sections
- C - Chemistry; metallurgy
- C07D - Heterocyclic compounds
- C07D 473/06 - Heterocyclic compounds containing purine ring systems with oxygen, sulfur, or nitrogen atoms directly attached in positions 2 and 6 two oxygen atoms with radicals containing only hydrogen and carbon atoms, attached in position 1 or 3
Patent holdings for IPC class C07D 473/06
Total number of patents in this class: 196
10-year publication summary
|
18
|
17
|
15
|
15
|
14
|
13
|
15
|
13
|
12
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Boehringer Ingelheim International GmbH | 4629 |
29 |
| Agency for Science, Technology and Research | 3512 |
8 |
| Hydra Biosciences, LLC | 16 |
8 |
| Allergan Sales, LLC | 258 |
7 |
| Teon Therapeutics, Inc. | 27 |
6 |
| SmithKline Beecham Corporation | 304 |
5 |
| Sun Pharmaceutical Industries Inc | 151 |
5 |
| Sunshine Lake Pharma Co., Ltd. | 542 |
5 |
| Impetis Biosciences Ltd. | 29 |
5 |
| Marvel Biotechnology | 6 |
5 |
| ATIR Holding S.A. | 18 |
3 |
| Biocon Limited | 228 |
3 |
| Concert Pharmaceuticals, Inc. | 254 |
3 |
| Eli Lilly and Company | 3645 |
3 |
| Jiangsu Tasly Diyi Pharmaceutical Co., Ltd. | 59 |
3 |
| Ranbaxy Laboratories Limited | 453 |
3 |
| Rheinische Friedrich-Wilhelms-Universität Bonn | 196 |
3 |
| Adenosine Therapeutics, LLC | 9 |
2 |
| Advinus Therapeutics Private Limited | 7 |
2 |
| CV Therapeutics, Inc. | 57 |
2 |
| Other owners | 86 |